Early Clinical Benefit of Semaglutide in Adults with Overweight or Obesity and Cardiovascular Disease: A Secondary Analysis of the SELECT Trial
Authors:
Jorge Plutzky1; John W. Ostrominski1; Vanita R. Aroda2; John Deanfield3; Scott S. Emerson4; G. Kees Hovingh5; Steven E. Kahn6; Sergio Leonardi7; Ildiko Lingvay8; Donna H. Ryan9; Søren Rasmussen5; Benjamin M. Scirica10; Signe Stensen5; Peter E. Weeke5; A. Michael Lincoff11